Werewolf Therapeutics (HOWL) Receivables - Other (2022 - 2024)

Werewolf Therapeutics (HOWL) has disclosed Receivables - Other for 3 consecutive years, with $464000.0 as the latest value for Q3 2024.

  • Quarterly Receivables - Other fell 92.15% to $464000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $464000.0 through Sep 2024, down 92.15% year-over-year, with the annual reading at $1.3 million for FY2023, 80.51% down from the prior year.
  • Receivables - Other for Q3 2024 was $464000.0 at Werewolf Therapeutics, down from $545000.0 in the prior quarter.
  • The five-year high for Receivables - Other was $6.9 million in Q4 2022, with the low at $300000.0 in Q1 2024.
  • Average Receivables - Other over 3 years is $2.9 million, with a median of $2.0 million recorded in 2022.
  • The sharpest move saw Receivables - Other surged 212.03% in 2023, then tumbled 92.15% in 2024.
  • Over 3 years, Receivables - Other stood at $6.9 million in 2022, then crashed by 80.51% to $1.3 million in 2023, then crashed by 65.63% to $464000.0 in 2024.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $464000.0, $545000.0, and $300000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.